Medicine – Antiseizure Drugs

Antiseizure medications, traditionally called antiepileptic drugs, reduce the frequency or terminate seizures by modifying neuronal excitability and neurotransmission. Different drugs act through different mechanisms, including blockade of voltage-gated sodium or calcium channels and enhancement of inhibitory GABAergic transmission.

Drug choice depends on the seizure type or epilepsy syndrome, patient characteristics, comorbidities, pregnancy potential, adverse-effect profile, and drug interactions. Some recommendations in the supplied table reflect older prescribing practice, so the notes below preserve the core material while updating important points.

1. Sodium Valproate

Sodium valproate is a broad-spectrum antiseizure medication effective against several seizure types.

Its mechanism is complex rather than truly “uncertain.” It increases inhibitory GABA activity and also affects voltage-gated sodium channels and other ion-channel mechanisms.

2. Indications for Valproate

Valproate is effective against:

Generalised tonic-clonic seizures.

Absence seizures.

Myoclonic seizures.

Focal seizures in some circumstances.

Because of its broad-spectrum activity, it has historically been described as effective for “all forms of epilepsy.”

However, calling it the universal drug of choice for tonic-clonic seizures is outdated. Selection now depends strongly on epilepsy type and individual patient factors.

3. Valproate and Generalised Epilepsy

Valproate can be particularly effective in generalised epilepsies, including those with myoclonic seizures.

However, its effectiveness must be balanced against its important adverse effects and reproductive risks.

Its use is especially restricted in people who could become pregnant because fetal exposure carries substantial risks.

4. Adverse Effects of Valproate

Important adverse effects include:

Tremor.

Weight gain.

Sedation.

Gastrointestinal disturbance.

Thrombocytopenia.

Hepatotoxicity.

Pancreatitis.

Hair loss can also occur.

5. Valproate and Pregnancy

Valproate has particularly important teratogenic and neurodevelopmental risks.

Fetal exposure increases the risk of:

Neural tube defects.

Other major congenital malformations.

Developmental impairment.

Adverse cognitive outcomes.

Autism spectrum disorder and other neurodevelopmental difficulties.

Therefore, valproate requires particularly careful reproductive counselling and is subject to major prescribing restrictions in many settings.

6. Phenytoin

Phenytoin primarily acts by blocking voltage-gated sodium channels.

It stabilises neuronal membranes and reduces repetitive high-frequency neuronal firing.

7. Uses of Phenytoin

Phenytoin has traditionally been used for:

Focal seizures.

Focal-to-bilateral tonic-clonic seizures.

Generalised tonic-clonic seizures in selected settings.

It also has an important role in the treatment of status epilepticus, although other agents are now frequently preferred depending on local protocols.

8. Phenytoin in Status Epilepticus

In established convulsive status epilepticus, a benzodiazepine is generally given first to terminate the seizure rapidly.

A longer-acting intravenous antiseizure medication is then used if required.

Modern protocols may use:

Levetiracetam.

Fosphenytoin/phenytoin.

Valproate.

Therefore, phenytoin remains relevant but is not the only option.

9. Adverse Effects of Phenytoin

Characteristic adverse effects include:

Gingival hyperplasia.

Hirsutism.

Coarsening of facial features.

Ataxia.

Nystagmus.

Drowsiness.

Diplopia.

Peripheral neuropathy with chronic exposure.

Hepatotoxicity.

10. Cerebellar Features of Phenytoin Toxicity

Excessive phenytoin concentrations can cause neurological toxicity.

Features include:

Nystagmus.

Ataxia.

Dysarthria.

Diplopia.

Drowsiness.

These neurological findings are useful clues to phenytoin toxicity.

11. Phenytoin and Vitamin Metabolism

Long-term phenytoin treatment can interfere with vitamin metabolism.

Important associations include:

Folate deficiency.

Vitamin D deficiency and impaired bone health.

It can also interact with vitamin K metabolism, which is particularly relevant in certain clinical contexts.

12. Phenytoin Pharmacology

Phenytoin has complex pharmacokinetics.

At higher concentrations, its metabolism can become saturated, meaning that:

A small dose increase can produce a disproportionately large rise in serum concentration.

This is why drug-level monitoring can be useful in selected patients.

13. Carbamazepine

Carbamazepine acts primarily by blocking voltage-gated sodium channels.

It reduces repetitive neuronal firing and is particularly useful in focal epilepsy.

14. Uses of Carbamazepine

Important indications include:

Focal seizures.

Focal-to-bilateral tonic-clonic seizures.

It has historically also been described for tonic-clonic seizures more generally, but seizure classification matters because carbamazepine can worsen certain generalised seizure types.

15. Carbamazepine Can Worsen Some Seizures

Carbamazepine is not appropriate for every epilepsy syndrome.

It may aggravate:

Absence seizures.

and

Myoclonic seizures.

Therefore, accurate classification of the patient’s epilepsy is important before prescribing it.

16. Other Uses of Carbamazepine

Outside epilepsy, carbamazepine is particularly well known for treating:

Trigeminal neuralgia.

It is also used in selected psychiatric conditions.

17. Adverse Effects of Carbamazepine

Important adverse effects include:

Dizziness.

Diplopia.

Ataxia.

Drowsiness.

Hepatotoxicity.

Hyponatraemia due to SIADH.

Rash.

Blood dyscrasias.

18. Carbamazepine and Blood Dyscrasias

Rare but potentially serious haematological complications include:

Leukopenia.

Agranulocytosis.

Aplastic anaemia.

Therefore, unexplained fever, infection, bruising, or bleeding requires appropriate assessment.

19. Carbamazepine and Severe Skin Reactions

Carbamazepine can cause severe cutaneous adverse reactions, including:

Stevens–Johnson syndrome.

Toxic epidermal necrolysis.

Genetic susceptibility is particularly relevant in certain ancestry groups, and HLA-B*1502 testing is important in appropriate populations before treatment.

20. Carbamazepine as an Enzyme Inducer

Carbamazepine induces hepatic enzymes.

This creates numerous drug interactions.

One important consequence is:

Reduced effectiveness of some hormonal contraceptives.

This is particularly relevant when counselling patients with epilepsy about pregnancy prevention.

21. Lamotrigine

Lamotrigine is a broad-spectrum antiseizure medication.

It primarily blocks voltage-gated sodium channels and reduces the release of excitatory neurotransmitters such as glutamate.

22. Uses of Lamotrigine

Lamotrigine can be used as monotherapy or adjunctive therapy for several seizure types, including:

Focal seizures.

Focal-to-bilateral tonic-clonic seizures.

Generalised tonic-clonic seizures.

It is also used in some generalised epilepsy syndromes.

23. Lamotrigine and Myoclonic Seizures

The original table lists lamotrigine for some myoclonic seizures.

This is possible, but an important nuance is that lamotrigine may occasionally worsen myoclonus in some patients.

Therefore, treatment should be tailored to the epilepsy syndrome.

24. Adverse Effects of Lamotrigine

Important adverse effects include:

Rash.

Headache.

Dizziness.

Diplopia.

Ataxia.

Tremor.

Nausea.

The most important serious adverse effect is a severe skin reaction.

25. Stevens–Johnson Syndrome

Lamotrigine can rarely cause:

Stevens–Johnson syndrome or toxic epidermal necrolysis.

Risk is increased by:

Starting at too high a dose.

Increasing the dose too rapidly.

Concurrent valproate therapy.

Therefore, lamotrigine must usually be started at a low dose and titrated gradually.

26. Lamotrigine and Pregnancy

Lamotrigine is commonly used when an antiseizure medication is required during pregnancy because available pregnancy data are comparatively reassuring relative to higher-risk drugs such as valproate.

However, pregnancy can increase lamotrigine clearance considerably.

Therefore:

Lamotrigine concentrations can fall during pregnancy → breakthrough seizures may occur.

Monitoring and dose adjustment may be necessary.

27. Gabapentin

Gabapentin was originally developed as a GABA analogue, but the table’s description that it simply “enhances GABA” is an oversimplification.

Its major clinically relevant action is binding to the:

α2δ subunit of voltage-gated calcium channels.

This reduces release of excitatory neurotransmitters.

28. Uses of Gabapentin

Gabapentin may be used as adjunctive therapy for:

Focal seizures.

However, it is now particularly familiar clinically for treating:

Neuropathic pain.

Examples include selected cases of painful peripheral neuropathy and other neuropathic pain syndromes.

29. Adverse Effects of Gabapentin

Important adverse effects include:

Drowsiness.

Dizziness.

Ataxia.

Peripheral oedema.

Weight gain.

Rash can occur but is not usually the defining adverse effect.

30. Ethosuximide

Ethosuximide is particularly associated with treatment of:

Absence seizures.

Its mechanism involves inhibition of T-type calcium channels in thalamic neurons.

These thalamocortical circuits are important in the generation of typical absence seizures.

31. Ethosuximide – High-Yield Association

The classic examination association is:

ABSENCE SEIZURES → ETHOSUXIMIDE.

It is particularly appropriate when a patient has pure absence epilepsy without other seizure types requiring a broader-spectrum medication.

32. Adverse Effects of Ethosuximide

Common adverse effects include gastrointestinal symptoms such as:

Nausea.

Vomiting.

Abdominal discomfort.

Other possible effects include:

Fatigue.

Headache.

Dizziness.

Rarely, significant blood dyscrasias can occur.

33. Benzodiazepines

Benzodiazepines enhance inhibitory neurotransmission through the:

GABA-A receptor.

More precisely, they are positive allosteric modulators rather than direct GABA agonists.

They increase the frequency of chloride-channel opening in the presence of GABA, increasing neuronal inhibition.

34. Benzodiazepines and Acute Seizures

Benzodiazepines are particularly important for:

Rapid termination of ongoing seizures.

and

Initial treatment of convulsive status epilepticus.

Examples include:

Lorazepam.

Diazepam.

Midazolam.

The exact choice depends on the clinical setting and route available.

35. Adverse Effects of Benzodiazepines

Important adverse effects include:

Sedation.

Drowsiness.

Dizziness.

Impaired coordination.

Respiratory depression.

Respiratory depression is especially important with high doses or when combined with other CNS depressants.

36. Status Epilepticus – Drug Sequence

A useful simplified approach is:

Ongoing convulsive seizure → benzodiazepine first.

If seizures continue:

Give a longer-acting intravenous antiseizure medication, according to the clinical protocol.

Options may include:

Levetiracetam.

Fosphenytoin/phenytoin.

Valproate.

Persistent refractory status requires escalation to critical-care management.

37. Important Modern Addition – Levetiracetam

Although it is absent from the older table, levetiracetam is now an important and commonly used antiseizure medication.

It binds to the synaptic vesicle protein:

SV2A.

This modifies neurotransmitter release and reduces seizure activity.

38. Uses of Levetiracetam

Levetiracetam is a broad-spectrum medication used for:

Focal seizures.

Generalised tonic-clonic seizures.

Myoclonic seizures in appropriate syndromes.

It is also widely used intravenously in acute neurological settings.

39. Adverse Effects of Levetiracetam

Important adverse effects include:

Somnolence.

Dizziness.

Fatigue.

Particularly important are behavioural or psychiatric effects such as:

Irritability.

Agitation.

Mood change.

These can occasionally limit treatment.

40. Antiseizure Drugs – Valproate Note Form

Mechanism: multiple actions, including increased GABA activity and effects on ion channels.

Uses: broad-spectrum; generalised tonic-clonic, absence and myoclonic seizures.

Important adverse effects: tremor, weight gain, sedation, hepatotoxicity and pancreatitis.

Major warning: significant teratogenic and neurodevelopmental fetal risk.

41. Phenytoin Note Form

Mechanism: voltage-gated sodium-channel blockade.

Uses: focal and tonic-clonic seizures; intravenous phenytoin/fosphenytoin can be used in status epilepticus after initial benzodiazepine treatment.

Classic adverse effects: gingival hyperplasia + hirsutism + coarse facial features.

Toxicity: nystagmus + ataxia + diplopia + drowsiness.

Long-term effects: folate/vitamin D abnormalities and peripheral neuropathy.

42. Carbamazepine Note Form

Mechanism: voltage-gated sodium-channel blockade.

Main epilepsy use: focal seizures and focal-to-bilateral tonic-clonic seizures.

Other classic use: trigeminal neuralgia.

Adverse effects: dizziness, diplopia, ataxia, hyponatraemia, hepatotoxicity, rash and blood dyscrasias.

Important warning: can worsen absence and myoclonic seizures.

Drug interaction: hepatic enzyme inducer.

43. Lamotrigine Note Form

Mechanism: sodium-channel blockade + reduced glutamate release.

Uses: broad-spectrum treatment, including focal and generalised tonic-clonic seizures.

Adverse effects: headache, dizziness, ataxia, tremor and rash.

Major warning: Stevens–Johnson syndrome/toxic epidermal necrolysis.

Prevention: start low and increase slowly.

Pregnancy: comparatively favourable option when clinically appropriate, but concentrations may fall during pregnancy.

44. Gabapentin Note Form

Mechanism: binds α2δ subunit of voltage-gated calcium channels.

Uses: adjunctive treatment of focal epilepsy and treatment of neuropathic pain.

Adverse effects: drowsiness, dizziness, ataxia, oedema and weight gain.

45. Ethosuximide Note Form

Mechanism: blocks thalamic T-type calcium channels.

Main indication: absence seizures.

Adverse effects: gastrointestinal disturbance, fatigue and headache; rare blood dyscrasias.

Memory association: Ethosuximide = absence epilepsy.

46. Benzodiazepines Note Form

Mechanism: enhance GABA-A receptor-mediated inhibition.

Main indication: acute termination of seizures/status epilepticus.

Examples: lorazepam, diazepam and midazolam.

Adverse effects: sedation, dizziness, impaired coordination and respiratory depression.

47. Levetiracetam Note Form

Mechanism: binds SV2A synaptic vesicle protein.

Uses: focal, generalised tonic-clonic and selected myoclonic seizures; also commonly used in acute seizure management.

Adverse effects: somnolence, fatigue, dizziness, irritability and behavioural/mood changes.

48. High-Yield Drug Associations

Absence seizure → Ethosuximide.

Acute ongoing seizure/status epilepticus → Benzodiazepine first.

Focal seizures → Lamotrigine, levetiracetam or carbamazepine are important options depending on the patient.

Myoclonic/generalised epilepsy → broad-spectrum therapy; valproate is highly effective but reproductive risks are crucial.

Neuropathic pain + antiseizure drug → Gabapentin.

Gingival hyperplasia + hirsutism + ataxia → Phenytoin.

Hyponatraemia + diplopia + blood dyscrasia → Carbamazepine.

Serious rash/Stevens–Johnson syndrome → Lamotrigine or carbamazepine are important associations.

Weight gain + tremor + hepatotoxicity + pancreatitis → Valproate.

Irritability/behavioural change → Levetiracetam.

Key Clinical Pattern

For rapid recall:

VALPROATE → broad-spectrum + weight gain/tremor + major pregnancy risk.

PHENYTOIN → Na⁺ blockade + gingival hyperplasia + hirsutism + ataxia.

CARBAMAZEPINE → Na⁺ blockade + focal seizures + hyponatraemia + blood dyscrasias.

LAMOTRIGINE → Na⁺ blockade/glutamate reduction + rash/SJS.

GABAPENTIN → α2δ calcium-channel subunit + neuropathic pain + sedation.

ETHOSUXIMIDE → T-type Ca²⁺ blockade + absence seizures.

BENZODIAZEPINES → enhance GABA-A + terminate acute seizures + respiratory depression.

LEVETIRACETAM → SV2A + broad-spectrum + behavioural adverse effects.